States – – altogether 17,676 vials – – were recalled. States that received shots include: California, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Maryland, Michigan, Minnesota, NEW YORK, New Hampshire, New Jersey, Nevada, NY, Ohio, Pennsylvania, Rhode Island, SC, Tennessee, Virginia, West and Texas Virginia. Hubby awaits meningitis test results pursuing wife’s deathFinding meningitis victims before it’s too lateDoctor calls for more regulation amid deadly meningitis outbreakThe business, which mixes medicines and is not subject to the same FDA authorization as a pharmaceutical business that manufactures drugs, extended its recall Saturday to add all other products the company manufactures. The business is licensed in all 50 states.Related StoriesNew RNA test of blood platelets can be used to identify location of cancerCrucial switch in single DNA foundation predisposes children to aggressive form of cancerCornell biomedical engineers develop 'super natural killer cells' to destroy cancer cells in lymph nodesBased on this discovery, researchers from BTI are suffering from a pipeline of mAbs for main cancers within Singapore. The partnership with Roche allows new diagnostic assessments and cancer remedies to be developed more quickly also to be brought earlier to patient treatment. Such remedies could complement and augment existing malignancy drugs and result in far better and safer remedies for cancer sufferers. Prof Lam Kong Peng, Executive Director of BTI, stated: This collaboration underscores the potency of BTI's antibody analysis and we can leverage on Roche's knowledge to develop novel antibody-based therapeutics.